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Introduction 
 
Stress-induced cardiomyopathy (also called Takotsubo 
cardiomyopathy, apical ballooning, or broken heart syn-
drome) was first reported in 1991 as “myocardial stun-
ning due to simultaneous multivessel coronary spasms: 
a review of 5 cases” by Japanese doctors,
1) and is well 
known disease entity now. This disease primarily affects 
postmenopausal women after psychological or physical 
stress.
2) Clinical characteristics are a triad of sudden on-
set of chest pain or dyspnea, electrocardiographic find-
ings with ST segment elevation and evolutional T-wave 
changes, and a moderate elevation in cardiac enzymes 
mimicking acute myocardial infarction.
3) As a precau-
tion, coronary angiography is usually performed to dif-
ferentiate from acute coronary syndrome. Even though 
many case and clinical study reports have been publi-
shed, the mechanisms of stress-induced cardiomyopathy 
(SCM) are still unknown. The pathophysiology of SCM 
is includes vasospasm of coronary arteries; disturbance 
of microcirculation; obstruction of the left ventricular 
outflow obstruction; catecholamine-mediated myocar-
dial stunning, which is an important link between emo-
tional or physical stress and cardiac injury; hormonal 
interactions; and inflammation.
4-7)  
 
Clinical Characteristics and  
Adverse Events 
 
Lee et al.
3) report some different clinical characteristics 
and prognoses of SCM in this issue. 
In their study,
 8) they found that in 32 of 39 patients 
(82%), a major triggering factor is physical stress due to 
medical illness or procedure, that common presenting 
symptoms are dyspnea (18/39, 46%) rather than chest 
pain, and that the prevalence of cardiogenic shock (13/39, 
33%) and mortality (3/39, 8%) are very high when com-
pared with the data reported by Gianni et al.
9) However, 
the data published recently by Song et al.
10) on a study 
done in Korean subjects is very similar to the data of 
Lee et al.
3) in clinical characteristics of SCM and the pre-
valence of cardiogenic shock. Additionally, according to 
these findings, racial differences may be a factor. The sig-
nificance of the interpretation of these studies is limited, 
however, because each has enrolled only a small num-
bers of patients and been carried out in a single center. 
 
Biomarkers in the Pathophysiology 
and Clinical Outcomes 
 
A study by Dorfman and Iskandrian
11) shows that se-
rum b-type natriuretic peptide (NT-proBNP) and catecho-
lamine level at presentation correlates with the Killip 
class of heart failure and associated complications, and 
low levels predict favorable outcomes. Madhavan et al.
12) 
has suggested that marked systemic inflammatory res-
ponse occurs in SCM, similar to those seen in acute myo-
cardial infarction, despite the absence of significant myo-
cardial injury. Morel et al.
7) recently published a study 
that shows that elevated C-reactive protein (CRP) levels 
were correlated with baseline left ventricular ejection frac-
tion (LVEF) and BNP levels, and that inflammatory st-
atus in SCM was related to LVEF impairment and to the 
extent of neurohormonal activation. Lee et al.
3) reported 
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similar findings, showing that elevated high-sensitivity 
CRP (hs-CRP) and decreased left ventricular systolic func-
tion at admission were related to death or cardiogenic 
shock.  
Hence, as described above, various biomarkers and cli-
nical parameters may act as prognostic and pathophy-
siological markers for SCM, but causal relationships 
are as yet unkown. Hs-CRP is non-specific inflamma-
tory marker, and many cases of SCM are triggered by 
physical stress such as a medical illness or surgical pro-
cedure. High levels of hs-CRP can be due to severity of 
the associated disease. Therefore, cases with cardioge-
nic shock or mortality should be reviewed for the se-
verity of the associated underlying disease. Also, in the 
study reported by Lee et al.
3) patients reported to have 
had cardiogenic shock should be reviewed and possible 
re-classified because the criteria for shock herein includ-
ed all types of shock and the prevalence of cardiogenic 
shock is thus very high in this study when compared 
with data from other studies showing favorable prognoses. 
In conclusion, a prospective, multicenter, large volume 
clinical study of SCM is needed. We have had many case 
reports and small, single-center study results and now 
know pathophysiology and clinical importance of SCM 
very well. Along with ongoing basic research on the car-
diac reaction to psychological and physical stress, a mul-
ticenter clinical trial would potentially show a straight-
forward correlation between the pathophysiology and 
clinical outcomes of SCM, and direct clinicians toward 
specific treatments.   
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